{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:32:50Z","timestamp":1790627570978,"version":"4.1.0"},"reference-count":39,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000774","name":"US | Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["Agreement number HDTRA1-07-9-00021"],"award-info":[{"award-number":["Agreement number HDTRA1-07-9-00021"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2023,5,17]]},"abstract":"<jats:p>\n            <jats:named-content content-type=\"genus-species\">Francisella tularensis<\/jats:named-content>\n            (\n            <jats:named-content content-type=\"genus-species\">F. tularensis<\/jats:named-content>\n            ) is a Centers for Disease Control (CDC) category \u201cA\u201d Gram-negative biothreat pathogen. Inhalation of\n            <jats:named-content content-type=\"genus-species\">F. tularensis<\/jats:named-content>\n            can cause pneumonia and respiratory failure and is associated with high mortality rates without early treatment.\n          <\/jats:p>","DOI":"10.1128\/aac.01381-22","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T14:02:44Z","timestamp":1682431364000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy of Intravenously Administered Gepotidacin in Cynomolgus Macaques following a Francisella tularensis Inhalational Challenge"],"prefix":"10.1128","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4839-0266","authenticated-orcid":true,"given":"Charles","family":"Jakielaszek","sequence":"first","affiliation":[{"name":"GSK Pharmaceuticals, Collegeville, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamese J.","family":"Hilliard","sequence":"additional","affiliation":[{"name":"GSK Pharmaceuticals, Collegeville, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Mannino","sequence":"additional","affiliation":[{"name":"GSK Pharmaceuticals, Collegeville, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hossain","sequence":"additional","affiliation":[{"name":"GSK Pharmaceuticals, Collegeville, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Qian","sequence":"additional","affiliation":[{"name":"GSK Pharmaceuticals, Collegeville, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2842-9063","authenticated-orcid":true,"given":"Cindy","family":"Fishman","sequence":"additional","affiliation":[{"name":"GSK Pharmaceuticals, Collegeville, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Liang","family":"Chou","sequence":"additional","affiliation":[{"name":"Battelle Biomedical Research Center (BBRC), Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Henning","sequence":"additional","affiliation":[{"name":"Battelle Biomedical Research Center (BBRC), Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Novak","sequence":"additional","affiliation":[{"name":"Battelle Biomedical Research Center (BBRC), Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samandra","family":"Demons","sequence":"additional","affiliation":[{"name":"U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Hershfield","sequence":"additional","affiliation":[{"name":"U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4168-9401","authenticated-orcid":false,"given":"Karen","family":"O\u2019Dwyer","sequence":"additional","affiliation":[{"name":"GSK Pharmaceuticals, Collegeville, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.15.4.631-646.2002"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005208"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12445"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a010314"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.carres.2013.06.015"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.6.2041-2046.1996"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.000550"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00448-17"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.56.012302.160616"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000443882"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00099"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00229"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.21.2763"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00122"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2017.03.022"},{"key":"e_1_3_2_17_2","unstructured":"Food and Drug Administration U.S. Department of Health and Human Services. 2015. Product development under the Animal Rule guidance for industry. http:\/\/www.fda.gov\/BiologicsBloodVaccines\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htm."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1961.03620050068007"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02820-15"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.8b00315"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09197"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00468-17"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky162"},{"key":"e_1_3_2_24_2","volume-title":"Abstr Eur Cong Clin Microbiol Infect Dis (ECCMID)","author":"Mushtaq S","year":"2019","unstructured":"Mushtaq S, Vickers A, Sadouki Z, Cole M, Fifer H, Nascimento VD, Day M, De Pinna E, Jenkins C, Godbole G, Woodford N. 2019. In-vitro activity of gepotidacin, a novel triazaacenaphthylene topoisomerase IV and DNA gyrase inhibitor, against multidrug-resistant Gram-negative bacteria and Staphylococcus saprophyticus. Abstr Eur Cong Clin Microbiol Infect Dis (ECCMID), Amsterdam, The Netherlands, 13 to 16 April, 2019."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00199-20"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00625-15"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00521-20"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.1892"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.3109\/00498254.2015.1112933"},{"key":"e_1_3_2_30_2","volume-title":"Abstr ASM Biothreat Res Response Policy Meet.","author":"Jakielaszek CG","year":"2017","unstructured":"Jakielaszek CG, O\u2019Dwyer K, Qian L, Demons S, Wu T. 2017. Novel antibiotic gepotidacin is active in vitro and efficacious in a rat aerosol challenge treatment model of Francisella tularensis infection. Abstr ASM Biothreat Res Response Policy Meet. American Society of Microbiology, Washington, DC."},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1080\/15287398509530647"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cimid.2015.01.003"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00086-19"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02385-16"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02095-16"},{"key":"e_1_3_2_36_2","volume-title":"Abstr 31st Eur Cong Clin Microbiol Infect Dis (ECCMID) Virtual Meet","author":"Barth A","year":"2021","unstructured":"Barth A, Hossain M, Tiffany C, Perry CR, Dumont EF. Distribution and exposure of gepotidacin (GSK2140944) in tissues and body fluids of healthy and infected participants, Abstr 31st Eur Cong Clin Microbiol Infect Dis (ECCMID) Virtual Meet, 9 to 12 July 2021."},{"key":"e_1_3_2_37_2","volume-title":"Abstr 54th Intersci Conf Antimicrob Agents Chemother","author":"Tiffany CA","year":"2014","unstructured":"Tiffany CA, Hossain M, McDonald M, Lerman S, Dumont EF. 2014. Safety and pharmacokinetics of repeat escalating IV doses of GSK2140944, a novel bacterial topoisomerase inhibitor. Abstr 54th Intersci Conf Antimicrob Agents Chemother. American Society for Microbiology, Washington, DC."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00115-16"},{"key":"e_1_3_2_39_2","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M07-A11.","author":"CLSI","year":"2018","unstructured":"CLSI. 2018. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M07-A11. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_2_40_2","volume-title":"Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. M45-A3.","author":"CLSI","year":"2015","unstructured":"CLSI. 2015. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. M45-A3. Clinical and Laboratory Standards Institute, Wayne, PA."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01381-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01381-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T13:08:11Z","timestamp":1684328891000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.01381-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,17]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,17]]}},"alternative-id":["10.1128\/aac.01381-22"],"URL":"https:\/\/doi.org\/10.1128\/aac.01381-22","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,17]]},"assertion":[{"value":"2022-10-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01381-22"}}